TECH vs VERX · P/E 65, rev $1.22B vs rev $748.4M
Bio-Techne Corp (TECH) versus Vertex (VERX) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Vertex (VERX) is a software - application company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VERX revenue for 2025-12-31 was $748.4M. Net income was $7.2M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. VERX currently screens at market cap $1.85B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VERX currently screens at market cap $1.85B.
Not investment advice. Open the TECH and VERX stock pages for the full models.
Not investment advice.